30135544|t|Glycosylation Significantly Inhibits the Aggregation of Human Prion Protein and Decreases Its Cytotoxicity.
30135544|a|Prion diseases are primarily caused by the misfolding of prion proteins in humans, cattle, sheep, and cervid species. The effects of glycosylation on prion protein (PrP) structure and function have not been thoroughly elucidated to date. In this study, we attempt to elucidate the effects of glycosylation on the aggregation and toxicity of human PrP. As revealed by immunocytochemical staining, wild-type PrP and its monoglycosylated mutants N181D, N197D, and T199N/N181D/N197D are primarily attached to the plasma membrane. In contrast, PrP F198S, a pathological mutant with an altered residue within the glycosylation site, and an unglycosylated PrP mutant, N181D/N197D, primarily exist in the cytoplasm. In the pathological mutant V180I, there is an equal mix of membranous and cytoplasmic PrP, indicating that N-linked glycosylation deficiency impairs the correct localization of human PrP at the plasma membrane. As shown by immunoblotting and flow cytometry, human PrP located in the cytoplasm displays considerably greater PK resistance and aggregation ability and is associated with considerably higher cellular ROS levels than PrP located on the plasma membrane. Furthermore, glycosylation deficiency enhances human PrP cytotoxicity induced by MG132 or the toxic prion peptide PrP 106-126. Therefore, we propose that glycosylation acts as a necessary cofactor in determining PrP localization on the plasma membrane and that it significantly inhibits the aggregation of human PrP and decreases its cytotoxicity.
30135544	56	61	Human	Species	9606
30135544	62	75	Prion Protein	Gene	5621
30135544	94	106	Cytotoxicity	Disease	MESH:D064420
30135544	108	122	Prion diseases	Disease	MESH:D017096
30135544	183	189	humans	Species	9606
30135544	191	197	cattle	Species	9913
30135544	199	204	sheep	Species	9940
30135544	258	271	prion protein	Gene	5621
30135544	273	276	PrP	Gene	5621
30135544	437	445	toxicity	Disease	MESH:D064420
30135544	449	454	human	Species	9606
30135544	455	459	PrP.	Gene	5621
30135544	514	517	PrP	Gene	5621
30135544	551	556	N181D	ProteinMutation	tmVar:p|SUB|N|181|D;HGVS:p.N181D;VariantGroup:4;CorrespondingGene:5621;CorrespondingSpecies:9606
30135544	558	563	N197D	ProteinMutation	tmVar:p|SUB|N|197|D;HGVS:p.N197D;VariantGroup:3;CorrespondingGene:5621;CorrespondingSpecies:9606
30135544	569	574	T199N	ProteinMutation	tmVar:p|SUB|T|199|N;HGVS:p.T199N;VariantGroup:0;CorrespondingGene:5621;RS#:775144659;CorrespondingSpecies:9606;CA#:9752103
30135544	575	580	N181D	ProteinMutation	tmVar:p|SUB|N|181|D;HGVS:p.N181D;VariantGroup:4;CorrespondingGene:5621;CorrespondingSpecies:9606
30135544	581	586	N197D	ProteinMutation	tmVar:p|SUB|N|197|D;HGVS:p.N197D;VariantGroup:3;CorrespondingGene:5621;CorrespondingSpecies:9606
30135544	647	650	PrP	Gene	5621
30135544	651	656	F198S	ProteinMutation	tmVar:p|SUB|F|198|S;HGVS:p.F198S;VariantGroup:2;CorrespondingGene:5621;RS#:74315405;CorrespondingSpecies:9606;CA#:256779
30135544	757	760	PrP	Gene	5621
30135544	769	774	N181D	ProteinMutation	tmVar:p|SUB|N|181|D;HGVS:p.N181D;VariantGroup:4;CorrespondingGene:5621;CorrespondingSpecies:9606
30135544	775	780	N197D	ProteinMutation	tmVar:p|SUB|N|197|D;HGVS:p.N197D;VariantGroup:3;CorrespondingGene:5621;CorrespondingSpecies:9606
30135544	843	848	V180I	ProteinMutation	tmVar:p|SUB|V|180|I;HGVS:p.V180I;VariantGroup:1;CorrespondingGene:5621;RS#:74315408;CorrespondingSpecies:9606;CA#:256782
30135544	902	905	PrP	Gene	5621
30135544	923	956	N-linked glycosylation deficiency	Disease	MESH:C536108
30135544	993	998	human	Species	9606
30135544	999	1002	PrP	Gene	5621
30135544	1074	1079	human	Species	9606
30135544	1080	1083	PrP	Gene	5621
30135544	1229	1232	ROS	Chemical	-
30135544	1245	1248	PrP	Gene	5621
30135544	1328	1333	human	Species	9606
30135544	1334	1337	PrP	Gene	5621
30135544	1338	1350	cytotoxicity	Disease	MESH:D064420
30135544	1362	1367	MG132	Chemical	MESH:C072553
30135544	1493	1496	PrP	Gene	5621
30135544	1587	1592	human	Species	9606
30135544	1593	1596	PrP	Gene	5621
30135544	1615	1627	cytotoxicity	Disease	MESH:D064420
30135544	Association	MESH:D064420	5621
30135544	Positive_Correlation	MESH:C072553	MESH:D064420
30135544	Association	MESH:C536108	RS#:74315408;HGVS:p.V180I;CorrespondingGene:5621
30135544	Positive_Correlation	MESH:C536108	HGVS:p.N181D;CorrespondingGene:5621
30135544	Association	MESH:C536108	5621
30135544	Association	MESH:C536108	5621

